Clinical Trials Directory

Trials / Completed

CompletedNCT00947635

Cholesterol and Fatty Acid Synthesis in Islet and Liver Transplant Patients and Effect of Dietary Intervention

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
46 (actual)
Sponsor
University of Alberta · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose is to investigate possible mechanisms of increased blood lipid levels following transplantation, and also to see if a comprehensive dietary intervention is effective in reducing blood lipid levels in post-transplant patients.

Detailed description

Post-transplantation patients frequently have an increase in blood lipid levels presumed to be due to immunosuppressive agents, however it is currently unknown the mechanisms by which this occurs. Dietary interventions have frequently been unsuccessful in these patients, which may be due to single-nutrient interventions and lack of support and guidance. This research will use stable isotope methods to estimate cholesterol and fatty acid synthesis to determine if these pathways are affected by immunosuppression in patients before and after islet and liver transplant. In addition, it will be determined if a multi-nutrient dietary intervention will be implemented post-transplant can reduce blood lipid levels in to prevent further polypharmacy these patients.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDietary intervention - supplementsSupplement bar \& spread formulated with key nutrients (fish oil, phytosterols, almonds, soy protein) shown to help in reducing blood lipid levels

Timeline

Start date
2005-11-01
Primary completion
2009-06-01
Completion
2009-06-01
First posted
2009-07-28
Last updated
2009-07-28

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00947635. Inclusion in this directory is not an endorsement.